Friedman, Claire

Publications

Sort by

Co-Author Network

Options for Adjuvant Therapy for Uterine Leiomyosarcoma. Current treatment options in oncology. 2018 Review GET IT
Times cited: 16
Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma. JAMA oncology. 2018 Academic Article GET IT
Times cited: 109
Atypical autoimmune adverse effects with checkpoint blockade therapies. Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Editorial Article GET IT
Times cited: 10
Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab. Journal of the National Cancer Institute. 2016 Academic Article GET IT
Times cited: 49
Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors: A Review. JAMA oncology. 2016 Review GET IT
Times cited: 555
Patient-Physician Communication in the 21st Century. Trends in immunology. 2016 Academic Article GET IT
Times cited: 1